[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Article
March 9, 1984

Brain Peptides as Intercellular Messengers: Implications for Medicine

Author Affiliations

From the Peptide Biology Laboratory, The Salk Institute, La Jolla, Calif.

JAMA. 1984;251(10):1310-1315. doi:10.1001/jama.1984.03340340050027
Abstract

THE FOLLOWING discussion examines the unique features of peptides as intercellular messengers. An intercellular messenger is defined as a substance released from one cell that is capable of modifying the functional activity of another neighboring or distant cell.1 The roles that particular brain peptides may play in regulating anterior pituitary and autonomic nervous system functions, and the potential impact of peptide biology on the future practice of medicine will also be considered.

Peptides are now recognized to be a class of intercellular messengers widely distributed throughout the nervous system, gastrointestinal (GI) tract, and pancreas of both vertebrate and invertebrate animals.1 During the last 20 years, the number of peptides identified within the brain and gut of animals has increased enormously (Table 1). The discovery of these peptides in animals has resulted from improved methods of biologic assay and the development of techniques for the isolation, purification, and microsequencing

References
1.
Vale W, Rivier C, Brown M:  Regulatory peptides of the hypothalamus .  Annu Rev Physiol 1977;29:473-527.Crossref
2.
Rivier J, Rivier C, Spiess J, et al:  High-performance liquid chromatographic purification of peptide hormones: Ovine hypothalamic amunine (corticotropin releasing factor) .  Anal Biochem 1983;127:258-266.Crossref
3.
Spiess J, Rivier J, Rivier C, et al:  Primary structure of corticotropin-releasing factor from ovine hypothalamus .  Proc Natl Acad Sci USA 1981;78:6517-6521.Crossref
4.
Kakidani H, Furutani Y, Takahashi H, et al:  Cloning and sequence analysis of cDNA for porcine β-neo-endorphin .  Nature 1982;298:245-249.Crossref
5.
Vale W, Brown M:  Neurobiology of peptides , in  The Neurosciences, Fourth Study Program . Cambridge, Mass, The MIT Press, 1979, pp 1027-1041.
6.
Hokfelt T, Johansson O, Ljungdahl A, et al:  Peptidergic neurons .  Nature 1980;284:515-521.Crossref
7.
Darnell JE:  Transcription-units for messenger RNA-production in eucaryotic-cells and their DNA viruses .  Prog Nucleic Acid Res Mol Biol 1979;22:327-353.
8.
Gilbert N:  Why genes in pieces?  Nature 1978;271:501-502.Crossref
9.
Rosenfeld MG, Lin CR, Amara SG, et al:  Calcitonin mRNA polymorphism: Peptide switching associated with alternative RNA splicing events .  Proc Natl Acad Sci USA 1982;79:1717-1721.Crossref
10.
Amara SG, Jonas V, Rosenfeld MG, et al:  Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products .  Nature 1982;298:240-244.Crossref
11.
Eipper BA, Mains RE:  Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides .  Endocr Rev 1980;1:1-27.Crossref
12.
Brown M, Vale W:  Bombesin: Putative mammalian neurogastrointestinal peptides .  Trends Neurosci 1979;2:95-97.Crossref
13.
Simpson JB:  The circumventricular organs and the central actions of angiotensin .  Neuroendocrinology 1981;32:248-256.Crossref
14.
Brown MR, Vale WW:  Glucoregulatory effects of neurogastrointestinal peptides: The diffuse neuroendocrine system , in  Diabetes Mellitus: Diagnosis and Treatment . Bowie, Md, Robert J. Brody Co, 1981, vol 5, pp 55-62.
15.
Fisher LA, Brown MR:  Corticotropin-releasing factor: Central nervous system effects on the sympathetic nervous system and cardiovascular regulation , in Ganten D, Pfaff D (eds):  Current Topics in Neuroendocrinology . New York, Springer Publishing Co Inc, 1983, 87-101.
16.
Brown MR, Fisher DA:  Glucoregulation and the sympathetic nervous system: CNS control by brain peptides , in  Peptides: Integrators of Cell and Tissue Functions . New York, Raven Press, 1980, pp 81-97.
17.
Swanson LW, Sawchenko PE:  Paraventricular nucleus: A site for the integration of neuroendocrine and autonomic mechanisms .  Neuroendocrinology 1980;31:410-417.Crossref
18.
Swanson LW, Sawchenko PE:  Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei .  Ann Rev Neurosci 1983;6:269-324.Crossref
19.
Brown MR:  Thyrotropin releasing factor: A putative CNS regulator of autonomic nervous system outflow .  Life Sci 1981;28:1789-1795.Crossref
20.
Brown M, Rivier J, Vale W:  Somatostatin-28: Selective action on the pancreatic β-cell and brain .  Endocrinology 1981;108:2391-2393.Crossref
21.
Brown MR, Fisher LA, Spiess J, et al:  Corticotropin-releasing factor (CRF): Actions on the sympathetic nervous system and metabolism .  Endocrinology 1982;111:928-931.Crossref
22.
Burgus R, Dunn TF, Desiderio D, et al:  Characterization of the hypothalamic hypophysiotropic TSH releasing factor (TRF) of ovine origin .  Nature 1970;226:321-325.Crossref
23.
Matsuo H, Baba Y, Nair R, et al:  Structure of the porcine LH- and FSH-releasing hormone I proposed amino acid sequence .  Biochem Biophys Res Comm 1971;43:1334-1339.Crossref
24.
Brazeau P, Vale W, Burgus R, et al:  Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone .  Science 1973;179:77-79.Crossref
25.
Vale W, Spiess J, Rivier C, et al:  Characterization of a 41 residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β-endorphin .  Science 1981;213:1394-1397.Crossref
26.
Spiess J, Rivier J, Vale W:  Characterization of rat hypothalamic growth hormone releasing factor .  Nature 1983;303:532-535.Crossref
27.
Bloom FE, Battenberg ELF, Rivier. J, et al:  Corticotropin releasing factor (CRF): Immunoreactive neurons and fibers in rat hypothalamus .  Regul Pept 1982;4:43-48.Crossref
28.
Swanson LW, Sawchenko PE, Rivier J, et al:  Organization of ovine corticotropin releasing factor (CRF)-immunoactive cells and fibers in the rat brain: An immunohistochemical study .  Neuroendocrinology 1983; 36:165-186.Crossref
29.
Segal DS, Mandell AJ:  Differential behavioral effects of hypothalamic polypeptides , in Prange AJ:  The Thyroid Axis, Drugs and Behavior . New York, Raven Press, 1974, pp 129-133.
30.
Yarbrough GC:  On the pharmacology of thyrotropin releasing hormone (TRH) , in  Progress in Neurobiology . New York, Pergamon Press, 1979, pp 291-312.
31.
Moss RL, McCann SM:  Induction of mating behavior in rats by luteinizing hormone-releasing factor .  Science 1973;181:177-179.Crossref
32.
Tache Y, Goto Y, Gunion M, et al:  Inhibition of gastric acid secretion by corticotropin-releasing factor .  Science 1983;222:935-937.Crossref
33.
Fisher LA, Rivier J, Rivier C, et al:  Corticotropin-releasing factor (CRF): Central effects on mean arterial pressure and heart rate in rats .  Endocrinology 1982;110:2222-2224.Crossref
34.
Corbin A:  From contraception to cancer: A review of the therapeutic applications of LHRH analogues as antitumor agents .  Yale J Biol Med 1982;55:27-47.
35.
Comite F, Cutler GB, Rivier J, et al:  Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone .  N Engl J Med 1982;305:1546-1550.Crossref
36.
Crowley WF, Vale WW, Rivier J, et al:  LHRH in hypogonadotropic hypogonadism , in Zatuchn GI, Shelton JD, Sciarra JJ (eds):  LHRH Peptides as Female and Male Contraceptives . New York, Harper & Row Publishers Inc, 1981, pp 321-333.
37.
Corbin A, Beattie CW, Jones R, et al:  Peptide contraception: Antifertility properties of LH-RH analogues .  Int J Gynaecol Obstet 1979;16:359-372.
38.
Brooks CMcC, Koizumi K, Sato A (eds):  Integrative Functions of the Autonomic Nervous System . New York, Elsevier-North Holland Inc, 1979, pp 1-508.
39.
McCarty R, Kopin IJ:  Stress-induced alterations in plasma catecholamines and behavior of rats: Effects of chlorisondamine and bretylium .  Behav Neural Biol 1979;27:249-265.Crossref
40.
Young JB, Landsberg L:  Sympathoadrenal activity in fasting pregnant rats .  J Clin Invest 1979;64:109-116.Crossref
41.
Brown MR, Fisher LA:  Brain peptide regulation of adrenal epinephrine secretion .  Am J Physiol , 1983, in press.
42.
Fisher LA, Kikkawa DO, Rivier JE, et al:  Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide .  Nature 1983; 305:534-536.Crossref
43.
Brown M, Tache Y, Fisher D:  Central nervous system actions of bombesin: Mechanism to induce hyperglycemia .  Endocrinology 1979; 105:660-665.Crossref
44.
Severs WB, Daniels-Severs AE:  Effects of angiotensin on the central nervous system .  Pharmacol Rev 1973;25:415-449.
45.
Rivier C, Rivier J, Vale W:  Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor .  Science 1982;218:377-379.Crossref
46.
Brown M, Rivier J, Vale W:  Bombesin: Potent effects on thermoregulation in the rat .  Science 1977;196:998-1000.Crossref
47.
Fisher LA, Brown MR:  Central nervous system actions of bombesin on cardiovascular regulation in the rat , abstracted.  Soc Neurosci 1983; 9:549.Crossref
48.
Brown M, Fisher D:  Thermoregulation and adrenomedullary activity: Coordinated adaptive responses to nutrient deprivation , abstracted.  Soc Neurosci 1979;5:85.
49.
Sims EA:  Experimental obesity, dietary-induced thermogenesis, and their clinical implications .  Clin Endocrinol Metabol 1976;5:377-395.Crossref
50.
Jung RJ, Shetty PS, James WPT, et al:  Reduced thermogenesis in obesity .  Nature 1979;279:322-323.Crossref
51.
Van Loon GR, Appel NM:  β-Endorphin-induced increases in plasma dopamine, norepinephrine, and epinephrine .  Res Commun Chem Pathol Pharmacol 1980;27:607-610.
52.
Goodman RH, Lund PK, Jacobs JW:  Pre-prosomatostatins .  J Biol Chem 1980;255:6549-6552.
53.
Hobart P, Crawford R, Shen L, et al:  Cloning and sequence analysis of cDNA encoding two distinct somatostatin precursors found in the endocrine pancreas of angler fish .  Nature 1980;228:137-141.Crossref
54.
Brown MR, Rivier J, Vale M:  Somatostatin: Central nervous system actions on glucoregulation .  Endocrinology 1979;104:1709-1715.Crossref
55.
Brown M, Ling N, Rivier J:  Somatostatin-28, somatostatin-14 and somatostatin analogs: Effects of thermoregulation .  Brain Res 1981; 214:127-135.Crossref
56.
Fisher DA, Brown M:  Somatostatin analog: Plasma catecholamine suppression mediated by the central nervous system .  Endocrinology 1980;107:714-718.Crossref
57.
Tache Y, Vale W, Rivier J, et al:  Brain regulation of gastric acid secretion in rats by neurogastrointestinal peptides .  Peptides 1981;2( (suppl 2) ):51-55.Crossref
58.
Zukin RS, Zukin SR:  Multiple opiate receptors: Emerging concepts .  Life Sci 1981;29:2681-2690.Crossref
59.
Quirion R, Hammer RP, Herkenham M, et al:  Phencyclidine (angel dust)/σ 'opiate' receptor: Visualization by tritium-sensitive film .  Proc Natl Acad Sci USA 1981;78:5881-5885.Crossref
60.
Petty MA, deJong W:  Enkephalins induce a centrally mediated rise in blood pressure in rats .  Brain Res 1983;260:322-325.Crossref
61.
Petty MA, deJong W, deWied D:  An inhibitory role of β-endorphin in central cardiovascular regulation .  Life Sci 1982;30:1835-1840.Crossref
62.
Faden AI, Holaday JW:  Opiate antagonists: A role in the treatment of hypovolemic shock .  Science 1979;205:317-318.Crossref
63.
Holaday JW, Ruvio B-A, Faden AI:  Thyrotropin releasing hormone improves blood pressure and survival in endotoxic shock .  Eur J Pharmacol 1981;74:101-105.Crossref
64.
Faris PL, Komisaruk BR, Watkins LR, et al:  Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia .  Science 1983;219:310-312.Crossref
65.
Veale WC, Kasting NW, Cooper KE:  Arginine vasopressin and endogenous antipyresis: Evidence and significance .  Fed Proc 1981;40:2750-2753.
66.
Kasting NW, Veale WL, Cooper KE, et al:  Vasopressin may mediate febrile convulsions .  Brain Res 1981;213:327-333.Crossref
×